EMA committee recommends marketing approval for Novartis’ Kisqali to help reduce risk of recurrence in people with HR+/HER2- early breast cancer: Basel Saturday, October 19, 202 ...

Neumora's lead asset, Navacaprant, shows weak efficacy in phase 2 trial. Read why we are not optimistic about NMRA's ...

The American Journal of Managed Care provides insights into the latest news and research in managed care across multimedia ...

Approval is based on Phase III INAVO120 results, showing the Itovebi™ (inavolisib)-based regimen more than doubled ...

Neuroscientists say they have determined how a brain cell surface molecule shapes the way certain neurons behave.

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the U.S. Food and Drug ...

Researchers in the US analyzed swine-origin influenza viruses, identifying key mutations that could reduce antiviral drug ...

Jenna Fischer, who is best known for her role as Pam in “The Office,” has announced that she was diagnosed with Stage 1 ...

I never thought I’d be making an announcement like this but here we are,” Fischer wrote in an emotional Instagram post.

I am now cancer free,’’ the actress announced on Instagram, noting that she was diagnosed with Stage 1 cancer in December and ...

Discover the heartbreaking journey of Alzheimer's disease, from forgotten memories to debilitating symptoms. Can psychedelics ...

Steven Mansoor, M.D., Ph.D., a physician–scientist at Oregon Health & Science University, and his research team made a ...